Your current location is:{Current column} >>Text
Two pig heart transplants succeed in brain
{Current column}1People have watched
Introduction2/2© Reuters. FILE PHOTO: A breeding sow is seen inside a barn on a family run pig farm near Driffie ...

By Nancy Lapid
(Reuters) - Surgeons at New York University (NYU) have successfully transplanted genetically-engineered pig hearts into two brain-dead people, researchers said on Tuesday, moving a step closer to a long-term goal of using pig parts to address the shortage of human organs for transplant.
The hearts functioned normally, with no signs of rejection during the three-day experiments in June and July, they said at a news conference.
The experiments followed the death in March of a 57-year-old man with terminal heart disease who made history two months earlier at the University of Maryland as the first person to receive a genetically modified pig heart. The reasons why his new heart eventually failed are still unclear.
NYU procured the hearts from pigs engineered by Revivicor Inc and screened them for viruses using an enhanced monitoring protocol, the researchers said. The hearts showed no evidence of a pig virus called porcine cytomegalovirus that was detected in the blood of the Maryland man and may have contributed to his death.
The pigs had four genetic modifications to prevent rejection and abnormal organ growth and six to help prevent incompatibilities between pigs and humans.
NYU researchers also transplanted pig kidneys into two brain-dead recipients in 2021.
For now, they believe xenotransplantation is safer in brain-dead recipients than in living patients and also more informative because biopsies can be done more often.
More-frequent testing provides tremendous detail, said Dr. Robert Montgomery, director of the NYU Langone Transplant Institute, and a recipient of a heart transplant at NYU. "We were able in real time to capture everything that was going on during that 72-hour period," he said.
The procurement, transport, transplant surgery, and immunosuppression were all performed the same way as in typical human heart transplants, the researchers said.
"Our goal is to integrate the practices used in a typical, everyday heart transplant, only with a nonhuman organ that will function normally without additional aid from untested devices or medicines," said Dr. Nader Moazami, surgical director of heart transplantation at NYU Langone.
The 72-hour experiments produced preliminary data, leaving many questions to be answered before starting human pig heart trials, he added.
Statement: The content of this article does not represent the views of FTI website. The content is for reference only and does not constitute investment suggestions. Investment is risky, so you should be careful in your choice! If it involves content, copyright and other issues, please contact us and we will make adjustments at the first time!
Tags:
Related articles
Asian stocks surge ahead of BOJ policy decision By Reuters
{Current column}By Ankur BanerjeeSINGAPORE (Reuters) - Asian stocks rallied on Friday as strong corporate earnings h ...
Read moreOil up over 2% on dollar stumble, demand pre
{Current column}-- The push and pull in crude prices continues with Tuesday’s rally triggered by the dollar’s drop t ...
Read moreStock market today: Dow adds more than 300 points ahead of inflation report By
{Current column}-- Stocks closed higher on Tuesday led by a jump in energy and big tech as investors awaited a duo o ...
Read more
Popular Articles
- 3M reaches tentative $10 billion pollution settlement with US cities
- Stock market today: Dow adds more than 300 points ahead of inflation report By
- Japan logs current account surplus for fourth month as trade gap narrows By Reuters
- Asian stocks pressured by weak Chinese data, Fed uncertainty By
- Capital One shares rebound after Warren Buffett makes near $1 billion bet on bank By Reuters
- Asian stocks teeter as Russia, rates and China risks weigh By Reuters
Latest articles
-
Biden's subdued reaction to OPEC+ cuts foreshadows economic slowdown, carries risk By Reuters
-
Stock market today: Dow shed 219 points as recession fears return By
-
Oil heads for first monthly gain this year as supply tightens By Reuters
-
Global factory output slumps as weak demand weighs By Reuters
-
Elon Musk plans AI startup to rival OpenAI
-
Key inflation data, Nike earnings, U.K. housing gloom